Pleun C.M. van Poppel

Vildagliptin Improves Endothelium-Dependent Vasodilatation in Type 2 Diabetes

Pleun C.M. van Poppel, Mihai G. Netea, Paul Smits et al. · Diabetes Care · 2011 · 112 citations · Full text

One week treatment with the IL-1 receptor antagonist anakinra leads to a sustained improvement in insulin sensitivity in insulin resistant patients with type 1 diabetes mellitus

Edwin J.P. van Asseldonk, Pleun C.M. van Poppel, Dov B. Ballak et al. · Clinical Immunology · 2015 · 68 citations · Full text

Insulin Resistance, Metabolic Syndrome, Type 1 +11

Insulin acutely activates metabolism of primary human monocytes and promotes a proinflammatory phenotype

Jacqueline M. Ratter, Julia I. P. van Heck, Hanne M. M. Rooijackers et al. · Journal of Leukocyte Biology · 2021 · 23 citations · Full text

Salvia Miltiorrhiza Root Water-Extract (Danshen) Has No Beneficial Effect on Cardiovascular Risk Factors. A Randomized Double-Blind Cross-Over Trial

Pleun C.M. van Poppel, Pauline Breedveld, Evertine J. Abbink et al. · PLoS ONE · 2015 · 15 citations · Full text

The dipeptidyl peptidase-4 inhibitor vildagliptin does not affect ex vivo cytokine response and lymphocyte function in patients with type 2 diabetes mellitus

Pleun C.M. van Poppel, Mark S. Gresnigt, Paul Smits et al. · Diabetes Research and Clinical Practice · 2014 · 14 citations

Inflammation, Diabetes Management, Autoimmune Disease +10